|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||9.24 - 9.24|
|52 Week Range||7.43 - 10.88|
|Beta (5Y Monthly)||0.74|
|PE Ratio (TTM)||13.59|
|Forward Dividend & Yield||0.18 (1.94%)|
|Ex-Dividend Date||Sept 21, 2023|
|1y Target Est||N/A|
Aspen Pharmacare Holdings ( JSE:APN ) Full Year 2023 Results Key Financial Results Revenue: R40.7b (up 5.4% from FY...
South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales. For the year ended June 30, Aspen recorded headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier. Aspen had bet big on a massive demand for COVID-19 vaccines emanating from Africa but as the panic around the pandemic waned it was left with a huge idle capacity, forcing it to scout for new partnerships for shoring up revenues and profits.
Key Insights Given the large stake in the stock by institutions, Aspen Pharmacare Holdings' stock price might be...